pharmaphorum
FEBRUARY 18, 2022
Bayer now says it expects to make €3 billion in sales for its prostate cancer treatment Nubeqa, up from an earlier estimate of €1 billion, after reviewing new data for the drug in metastatic hormone-sensitive tumours. The post Bayer triples sales forecast for prostate cancer drug Nubeqa appeared first on.
World of DTC Marketing
DECEMBER 1, 2020
We all know that Wall Street and sales come well before patients. Just look at any pharma product website that is nothing but a sales brochure in a majority of cases. ROI drives pharma companies. In the past, pharma product websites had a huge effect on whether a patient asks for an Rx. Want proof?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
APRIL 5, 2022
Today, colossal budget product launches are not returning the same ROI as before. Product launches are going to need to be micro-targeted to specific audiences. What is the definition of a successful pharma product launch? HCP marketing is changing very quickly. The other challenge is going to be flexibility.
pharmaphorum
JANUARY 8, 2021
The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. With medical staff working tirelessly and lockdown restrictions in place across the world, the way pharma markets medications has changed, too.
Pharmaceutical Technology
MARCH 10, 2023
The pharmaceutical freeze-drying systems market is expected to be driven by the integration of smarter technologies in lyophilisation methods such as electron microscopy, biochemistry, and advancement in surgeries. The companies offer systems for more dynamic freeze-drying of products with more precision in control.
World of DTC Marketing
FEBRUARY 17, 2021
DTC marketers will do a lot of research on brand messaging, but what’s really important is what action your target audience will take due to being exposed to your message. Under no circumstances should ANY DTC marketer believe that a patient is going to ask their doctor about/for your product as a result of seeing your DTC TV ad.
pharmaphorum
JULY 14, 2022
Grünenthal is paying up to €500 million ($501 million) for rights to Nebido (testosterone undecanoate), which is sold in around 80 countries worldwide for testosterone deficiency and made sales of €117 million last year.
Expert insights. Personalized for you.
95 
Let's personalize your content